SAMANTHA HANCOCK: Open Payments
NPI 1518396951 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 18 payments from 8 companies in 2025. Trend: 2023 $279 · 2024 $520 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $101 |
| Organon LLC | 4 | $86 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Botanix SB Inc | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: OPZELURA, Sotyktu, Zoryve, VTAMA, SOFDRA, TREMFYA, NEMLUVIO, TALTZ.
Industry payments across VA — which companies pay providers there.
